HUM-MOLGEN events: Proteomics

HUM-MOLGEN -> Events -> Meetings and Conferences

March 18, 2002

ACI, Boston
April 11-12, 2002

ACI has assembled leading proteomic scientists from around the world to detail their latest findings at Proteomics, April 11-12 in Boston. At Proteomics, you will discover how leading pharmaceutical and biotech companies are already tapping into the potential of proteomics.

Organized by:

ACI

Invited Speakers:

Confirmed speakers include:

Dr. Stanley Hefta
Executive Director of Proteomics
Bristol-Myers Squibb

Dr. Joshua LaBaer
Director
Harvard Institute of Proteomics

Dr. Scott Patterson
Senior Director of Proteomics
Celera Genomics

Dr. Dario Valenzeula
Director of Functional Genomics
AlphaGene

Dr. Mary Jo Ondrechen
Professor of Chemistry
Northeastern University

Dr. Peter James
Professor of Protein Technology, Director of SWEGENE
Lund University (Sweden)

Akira Tsugita
Director, NEC LAB; Proteomics Research Lab
Science University of Tokyo (Japan)

Dr. Steven Cohen
Director of Life Science Technology
Waters Corporation

Dr. Mary Lopez
EVP, Proteomics R&D
Proteome Systems

Dr. Alexander Kamb
VP Research
Deltagen Proteomics

Professor Gary Pielak
Department of Chemistry
University of North Carolina

Andrzej Joachimiak
Director, Senior Biophysicist
Argonne National Laboratory/ Structural Biology Center

Dr. Pat Griffin
Senior Director, Proteomic Research and Basic Chemistry Analytical Support
Merck

Hayes McDonald
Senior Research Associate
Scripps Research Institute

Steve Martin
Director of Discovery Proteomics & Proteomics Research Center
Applied Biosystems

Dr. John Wiktorowicz
Director of Proteomics
Lynx Therapeutics

Dr. Stephen Kingsmore
Chief Operating Officer
Molecular Staging

Deadline for Abstracts:

n/a

Registration:

Call 312-780-0700 or online at www.acius.net/?cID=102

E-mail:

bchiarito@acius.net

Posted by:

Bob Chiarito

Host:

smtpgw.acius.net